Skip to main content
Clinical Trials/JPRN-UMIN000042962
JPRN-UMIN000042962
Completed
未知

A prospective observational study of immune-related adverse events, treatment efficacy, and pre-existing autoantibodies in patients with small-cell lung cancer who was treated by immune checkpoint inhibitor - Pre-existing autoantibodies and irAE in SCLC patients treated with ICI

Kobe City Medical Center General Hospital Respiratory Medicine0 sites54 target enrollmentJanuary 15, 2021

Overview

Phase
未知
Intervention
Not specified
Conditions
Patients with small cell lung cancer who was treated by chemotherapy plus immune checkpoint inhibitor as first line therapy
Sponsor
Kobe City Medical Center General Hospital Respiratory Medicine
Enrollment
54
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 15, 2021
End Date
January 30, 2023
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Kobe City Medical Center General Hospital Respiratory Medicine

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Patients who were determined as unsuitable by attending physician

Outcomes

Primary Outcomes

Not specified

Similar Trials